Meprobamate dependence secondary to carisoprodol (Soma) use.
Littrell
R A
RA
Chandler Medical Center, University of Kentucky, Lexington.
Sage
T
T
Miller
W
W
D000328:Adult; D001711:Biotransformation; D002328:Carisoprodol / Q000009:adverse effects / Q000493:pharmacokinetics; D005260:Female; D006801:Humans; D008620:Meprobamate / Q000009:adverse effects / Q000493:pharmacokinetics; D008657:Metabolic Clearance Rate; D009460:Neurologic Examination / Q000187:drug effects; D017288:Pain Threshold / Q000187:drug effects; D010348:Patient Care Team; D013375:Substance Withdrawal Syndrome / Q000097:blood / Q000209:etiology* / Q000534:rehabilitation; D019966:Substance-Related Disorders / Q000097:blood / Q000209:etiology* / Q000534:rehabilitation
D002328:Carisoprodol; D008620:Meprobamate